232 related articles for article (PubMed ID: 12878496)
1. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.
Pérez-Victoria FJ; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2003 Aug; 47(8):2397-403. PubMed ID: 12878496
[TBL] [Abstract][Full Text] [Related]
2. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
[TBL] [Abstract][Full Text] [Related]
3. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
[TBL] [Abstract][Full Text] [Related]
5. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
[TBL] [Abstract][Full Text] [Related]
6. Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
Saint-Pierre-Chazalet M; Ben Brahim M; Le Moyec L; Bories C; Rakotomanga M; Loiseau PM
J Antimicrob Chemother; 2009 Nov; 64(5):993-1001. PubMed ID: 19749205
[TBL] [Abstract][Full Text] [Related]
7. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
Paris C; Loiseau PM; Bories C; Bréard J
Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
[TBL] [Abstract][Full Text] [Related]
8. Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.
Vacchina P; Norris-Mullins B; Abengózar MA; Viamontes CG; Sarro J; Stephens MT; Pfrender ME; Rivas L; Morales MA
Antimicrob Agents Chemother; 2016 Jul; 60(7):4089-100. PubMed ID: 27114280
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
10. Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.
Luque-Ortega JR; Rivas L
Antimicrob Agents Chemother; 2007 Apr; 51(4):1327-32. PubMed ID: 17283192
[TBL] [Abstract][Full Text] [Related]
11. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance.
Pérez-Victoria FJ; Gamarro F; Ouellette M; Castanys S
J Biol Chem; 2003 Dec; 278(50):49965-71. PubMed ID: 14514670
[TBL] [Abstract][Full Text] [Related]
12. Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani.
Kulshrestha A; Sharma V; Singh R; Salotra P
Parasitol Res; 2014 Mar; 113(3):1171-84. PubMed ID: 24449447
[TBL] [Abstract][Full Text] [Related]
13. Defeating Leishmania resistance to miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: a proof of mechanism for trypanosomatid chemotherapy.
Luque-Ortega JR; de la Torre BG; Hornillos V; Bart JM; Rueda C; Navarro M; Amat-Guerri F; Acuña AU; Andreu D; Rivas L
J Control Release; 2012 Aug; 161(3):835-42. PubMed ID: 22609351
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
Mishra J; Singh S
Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
[TBL] [Abstract][Full Text] [Related]
15. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
Verma NK; Singh G; Dey CS
Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
[TBL] [Abstract][Full Text] [Related]
16. Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.
Veronica J; Chandrasekaran S; Dayakar A; Devender M; Prajapati VK; Sundar S; Maurya R
FEBS J; 2019 Sep; 286(17):3488-3503. PubMed ID: 31087522
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca
Pinto-Martinez AK; Rodriguez-Durán J; Serrano-Martin X; Hernandez-Rodriguez V; Benaim G
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061745
[No Abstract] [Full Text] [Related]
18. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
Tripathi P; Jaiswal AK; Dube A; Mishra PR
Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750
[TBL] [Abstract][Full Text] [Related]
19. Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
Deep DK; Singh R; Bhandari V; Verma A; Sharma V; Wajid S; Sundar S; Ramesh V; Dujardin JC; Salotra P
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005641. PubMed ID: 28575060
[TBL] [Abstract][Full Text] [Related]
20. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
